Peer-influenced content. Sources you trust. No registration required. This is HCN.
Clinical Advances in Hematology & Oncology
Artificial intelligence tools are increasingly being integrated into prostate cancer imaging, pathology, prognostication, and treatment planning. Although several platforms have demonstrated promising accuracy and workflow benefits, broad clinical adoption will require prospective validation, regulatory oversight, and careful implementation.
Health Informatics September 3rd 2026
Renal & Urology News
A randomized noninferiority trial involving 648 men with MRI-visible prostate lesions found that cognitive fusion biopsy achieved clinically significant prostate cancer detection rates similar to software-based fusion biopsy. Subgroup analyses suggested body mass index may influence the relative performance of each approach.
Medical Oncology July 29th 2026
Journal of Invasive Cardiology (JIC)
A post-CABG patient underwent transcatheter coil occlusion of a 51 x 39-mm saphenous vein graft aneurysm and died hours after discharge from anterior MI attributed to external LIMA compression.
Cardiology May 5th 2026
Rare Disease Advisor
An AI model trained on ECG images identified patients with ATTR‑CM across multiple cohorts, highlighting a potential scalable approach to improving early detection.
Cardiology April 21st 2026
Annals of Internal Medicine
Supplemental MRI for women with extremely dense breasts and higher-than-average risk “could be cost-effective if MRI costs and false-positive biopsy rates are reduced.” — Tosteson et al., Annals of Internal Medicine
Medical Oncology April 14th 2026
MDLinx
“The first thing that should come to mind as a clinician when evaluating headache in the ER is the SNOOP criteria. This will help you assess for potential red flags in a patient with a headache.”
Emergency Medicine December 2nd 2025